CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report)’s stock price traded down 5.6% during mid-day trading on Wednesday . The stock traded as low as $0.69 and last traded at $0.70. 104,777 shares traded hands during trading, a decline of 86% from the average session volume of 724,853 shares. The stock had previously closed […]
Avoro Capital Advisors LLC boosted its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 690.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,555,555 shares of the biotechnology company’s stock after buying an additional 6,600,000 shares during the […]
Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company’s stock after purchasing an additional 5,480,052 shares during the quarter. […]
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 871,200 shares, a drop of 29.7% from the April 30th total of 1,240,000 shares. Based on an average daily volume of 148,400 shares, the days-to-cover […]